EUDA Health Holdings Limited (NasdaqCM:EUDA) signed a letter of intent to acquire TheoremRx Inc. on October 4, 2023. Under the letter of intent, TheoremRx would merge with a subsidiary of EUDA. The transaction is subject to the negotiation of a definitive agreement, regulatory approvals, and the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 USD | -0.40% | -1.19% | +74.83% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+74.83% | 86.57M | |
-4.87% | 29.6B | |
+31.35% | 8.65B | |
-28.91% | 2.69B | |
-9.91% | 1.6B | |
-21.02% | 1.36B | |
-35.78% | 1.1B | |
+3.28% | 924M | |
-43.36% | 791M | |
-22.74% | 683M |
- Stock Market
- Equities
- EUDA Stock
- News EUDA Health Holdings Limited
- EUDA Health Holdings Limited signed a letter of intent to acquire TheoremRx Inc.